| Lung adenocarcinoma promotion by air pollutants W Hill, EL Lim, CE Weeden, C Lee, M Augustine, K Chen, FC Kuan, ... Nature 616 (7955), 159-167, 2023 | 191 | 2023 |
| The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic AM Frankell, SG Jammula, X Li, G Contino, S Killcoyne, S Abbas, J Perner, ... Nature genetics 51 (3), 506-516, 2019 | 189 | 2019 |
| The evolution of lung cancer and impact of subclonal selection in TRACERx AM Frankell, M Dietzen, M Al Bakir, EL Lim, T Karasaki, S Ward, ... Nature 616 (7957), 525-533, 2023 | 82 | 2023 |
| Antibodies against endogenous retroviruses promote lung cancer immunotherapy KW Ng, J Boumelha, KSS Enfield, J Almagro, H Cha, O Pich, T Karasaki, ... Nature 616 (7957), 563-573, 2023 | 81 | 2023 |
| Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA C Abbosh, AM Frankell, T Harrison, J Kisistok, A Garnett, L Johnson, ... Nature 616 (7957), 553-562, 2023 | 78 | 2023 |
| Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling E Ococks, AM Frankell, NM Soler, N Grehan, A Northrop, H Coles, ... Annals of Oncology 32 (4), 522-532, 2021 | 66 | 2021 |
| Abstract CT023: Phylogenetic tracking and minimal residual disease detection using ctDNA in early-stage NSCLC: A lung TRACERx study C Abbosh, A Frankell, A Garnett, T Harrison, M Weichert, A Licon, ... Cancer Research 80 (16_Supplement), CT023-CT023, 2020 | 56 | 2020 |
| The evolution of non-small cell lung cancer metastases in TRACERx M Al Bakir, A Huebner, C Martínez-Ruiz, K Grigoriadis, TBK Watkins, ... Nature 616 (7957), 534-542, 2023 | 55 | 2023 |
| Genomic–transcriptomic evolution in lung cancer and metastasis C Martínez-Ruiz, JRM Black, C Puttick, MS Hill, J Demeulemeester, ... Nature 616 (7957), 543-552, 2023 | 46 | 2023 |
| Using DNA sequencing data to quantify T cell fraction and therapy response R Bentham, K Litchfield, TBK Watkins, EL Lim, R Rosenthal, ... Nature 597 (7877), 555-560, 2021 | 41 | 2021 |
| Evolutionary characterization of lung adenocarcinoma morphology in TRACERx T Karasaki, DA Moore, S Veeriah, C Naceur-Lombardelli, A Toncheva, ... Nature medicine 29 (4), 833-845, 2023 | 32 | 2023 |
| Body composition and lung cancer-associated cachexia in TRACERx O Al-Sawaf, J Weiss, M Skrzypski, JM Lam, T Karasaki, F Zambrana, ... Nature medicine 29 (4), 846-858, 2023 | 18 | 2023 |
| Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Fitzgerald RC. The landscape of selection in 551 esophageal adenocarcinomas defines genomic … AM Frankell, S Jammula, X Li, G Contino, S Killcoyne, S Abbas, J Perner, ... Nat Genet 51, 506-16, 2019 | 16 | 2019 |
| CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction K Grigoriadis, A Huebner, A Bunkum, E Colliver, AM Frankell, MS Hill, ... Nature Protocols 19 (1), 159-183, 2024 | 7 | 2024 |
| cloneMap: a R package to visualise clonal heterogeneity AM Frankell, E Colliver, N Mcgranahan, C Swanton bioRxiv, 2022.07. 26.501523, 2022 | 4 | 2022 |
| ctDNA in gastric and gastroesophageal cancer: prognostic, predictive, or preliminary? AM Frankell, EC Smyth Clinical Cancer Research 25 (23), 6893-6895, 2019 | 4 | 2019 |
| Clonal evolution in healthy and premalignant tissues: implications for early cancer interception strategies JK Rane, AM Frankell, CE Weeden, C Swanton Cancer Prevention Research 16 (7), 369-378, 2023 | 3 | 2023 |
| When can we be confident of surgical cure with ctDNA? A Frankell, M Jamal-Hanjani Nature Reviews Clinical Oncology 19 (9), 571-572, 2022 | 3 | 2022 |
| Barrett’s Esophagus: Emerging Evidence for Improved Clinical Practice D Pleskow, T Erim Academic Press, 2016 | 2 | 2016 |
| LBA55 An ultra-sensitive and specific ctDNA assay provides novel pre-operative disease stratification in early stage lung cancer JRM Black, AM Frankell, S Veeriah, M Colopi, M Hill, CW Abbott, ... Annals of Oncology 34, S1294, 2023 | 1 | 2023 |
Charles SwantonFrancis Crick InstituteVerified email at crick.ac.uk
